Four questions to predict cognitive decline in de novo Parkinson’s disease

Four questions to predict cognitive decline in de novo Parkinson’s disease

Early identification of cognitive decline (CD) in de novo Parkinson’s disease (PD) is crucial for choosing appropriate therapies and recruiting for clinical trials. However, existing prognostic models lack flexibility, scalability and require costly instrumentation. This study explores the utility of standard clinical questionnaires and criteria to predict CD in de novo PD. A total of 186 patients from the Parkinson Progression Markers Initiativ…

Parkinson is the world's fastest growing neurological disease, so experts stress the importance of correct diagnosis and effective treatment